Gilead Sciences Inc. (GILD)

Last Three Months

19-Jan-24 -- 18-Apr-24

Time Period:

Three Months
|
Year

($890.90K) Net Amount

Buy:	0	--
Sell:	($890.90K)	$72.74 - $73.18

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

35

0

7

+1

0

+2

0

+3

Two Year Chart

19-Apr-22 -- 18-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Mar-24 9:11 PM View:	10-Mar-24 Payment of Exercise ($1.04M)	O'Day Daniel Patrick Chairman & CEO Director		Gilead Sciences Inc. - GILD	53% 317.28K to 484.85K	0	0	--	--	Show Txns Hide Txns

11-Mar-24 9:03 PM View:	10-Mar-24 Payment of Exercise ($342.47K)	Mercier Johanna Chief Commercial Officer		Gilead Sciences Inc. - GILD	92% 61.6K to 118.43K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 6:38 PM View:	01-Apr-24 Market Sale (Planned) ($145.92K)	Parsey Merdad Chief Medical Officer		Gilead Sciences Inc. - GILD	95% 49.47K to 96.3K	0	($890.90K) (25%)	--	$72.74 - $73.18	Show Txns Hide Txns

11-Mar-24 8:59 PM View:	10-Mar-24 Payment of Exercise ($338.42K)	Dickinson Andrew D Chief Financial Officer		Gilead Sciences Inc. - GILD	73% 77.89K to 134.98K	0	0	--	--	Show Txns Hide Txns

12-Mar-24 4:19 PM View:	10-Mar-24 Payment of Exercise ($63.55K)	Telman Deborah H EVP, Corporate Affairs & GC		Gilead Sciences Inc. - GILD	103% 6.76K to 13.76K	0	0	--	--	Show Txns Hide Txns

12-Mar-24 3:57 PM View:	10-Mar-24 Payment of Exercise ($59.34K)	Patterson Sandra SVP, Controllership		Gilead Sciences Inc. - GILD	6% 30.74K to 32.63K	0	0	--	--	Show Txns Hide Txns

06-Feb-24 6:01 PM View:	02-Feb-24 Grant 0	Love Ted W Director		Gilead Sciences Inc. - GILD	100% 0 to 0.51K	0	0	--	--	Show Txns Hide Txns